Nephros Inc (NEPH) financial statements (2021 and earlier)

Company profile

Business Address 380 LACKAWANNA PLACE
SOUTH ORANGE, NJ 07079
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8452011
Cash and cash equivalents8452011
Receivables1111000
Inventory, net of allowances, customer advances and progress billings5321010
Inventory5321010
Prepaid expense00    0
Deferred costs  (1)(1)(1)(1)(1)
Deposits current assets      0
Capital leases, lessor balance sheet, net investment in direct financing and sales type leases 00  
Other current assets  00000
Other undisclosed current assets0011110
Total current assets:15884122
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0000000
Long-term investments and receivables   0   
Capital leases, lessor balance sheet, net investment in direct financing and sales type leases 0   
Intangible assets, net (including goodwill)22111  
Goodwill111    
Intangible assets, net (excluding goodwill)11111  
Other noncurrent assets0000012
Other undisclosed noncurrent assets  1 0  
Total noncurrent assets:3321122
TOTAL ASSETS:1912115343
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1111111
Accounts payable0111111
Accrued liabilities0000000
Employee-related liabilities      0
Debt0111   
Business combination, contingent consideration, liability 00    
Deferred revenue and credits0000
Other undisclosed current liabilities0     (0)
Total current liabilities:1232111
Noncurrent Liabilities
Long-term debt and lease obligation22111  
Long-term debt, excluding current maturities11111  
Operating lease, liability11
Liabilities, other than long-term debt  00000
Deferred revenue and credits0000
Business combination, contingent consideration, liability  0    
Other undisclosed noncurrent liabilities(1)0    7
Total noncurrent liabilities:2211108
Total liabilities:3443219
Stockholders' equity
Stockholders' equity attributable to parent1354213(6)
Common stock0000000
Additional paid in capital144132128123121120108
Accumulated other comprehensive income0000000
Accumulated deficit(132)(127)(124)(121)(120)(117)(114)
Stockholders' equity attributable to noncontrolling interest333    
Total stockholders' equity:1687213(6)
TOTAL LIABILITIES AND EQUITY:1912115343

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues91064222
Revenue, net4222
Cost of revenue
(Cost of Goods and Services Sold)
(4)(4)(2)(2)(1)(1)(1)
Other undisclosed gross profit      0
Gross profit:5632111
Operating expenses(9)(9)(6)(5)(4)(4)(4)
Operating loss:(4)(3)(3)(2)(3)(3)(3)
Nonoperating income (expense)(0)(0)(0)(0)000
Investment income, nonoperating   00  
Foreign currency transaction gain (loss), before tax   (0)0 0
Other nonoperating income (expense)(0)(0)(0)(0)000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(5)(3)(3)(3)(3)(3)(3)
Other undisclosed income from continuing operations before income taxes0 00   
Loss from continuing operations before income taxes:(5)(3)(3)(3)(3)(3)(3)
Income tax benefit 002   
Loss before gain (loss) on sale of properties:(5)(3)(3)(1)(3)(3)(3)
Other undisclosed net loss    (0)  
Net loss:(5)(3)(3)(1)(3)(3)(3)
Net loss attributable to noncontrolling interest (0)(0)    
Other undisclosed net income (loss) attributable to parent     0(4)
Net loss attributable to parent:(5)(3)(3)(1)(3)(3)(7)
Undistributed earnings (loss) allocated to participating securities, basic(0)   
Other undisclosed net loss available to common stockholders, basic     (0) 
Net loss available to common stockholders, diluted:(5)(3)(3)(1)(3)(3)(7)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(5)(3)(3)(1)(3)(3)(3)
Other undisclosed comprehensive income (loss)0(0)     
Comprehensive loss:(5)(3)(3)(1)(3)(3)(3)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)0(0)    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (0)0(0)0(4)
Comprehensive loss, net of tax, attributable to parent:(5)(3)(3)(1)(3)(3)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: